News

SEARCH FIRM NEWS

news April 16, 2026

Rend Al-Mondhiry Quoted in “Q&A: Navigating Compliance in the Non-Alc and Functional Beverage Space with Rend Al-Mondhiry”

In a Q&A with The Daily Pour, Rend Al-Mondhiry discussed how she helps scaling brands stay ahead of retail scrutiny by building airtight compliance habits before they hit the shelf.

news April 10, 2026

Jennifer Adams Quoted in “NAD Flags Bayer One A Day Men’s Fertility Positioning”

NutraIngredients turned to Jennifer Adams for comment on an NAD decision on April 8, 2026. The case involved a series of claims tied to Bayer HealthCare’s One A Day Men’s Pre-Conception Health Complete Multivitamin. The NAD recommended that the company modify its claims and concluded that its messaging conveyed unsupported fertility benefits.

news March 30, 2026

Bob Durkin Quoted in “Makers of Dietary Supplements Push the FDA to Allow Peptides and Other New Ingredients”

Commenting on a public meeting held by the FDA to discuss its criteria for dietary supplements and whether they could be broadened to include substances that don’t come from food, vitamins, herbs or other traditional ingredients, Bob Durkin told PBS News, “The hope of the meeting is that FDA is willing to open up its […]

news March 27, 2026

Bob Durkin Quoted in “Dietary Supplement Makers Push FDA to Allow New Ingredients”

For its coverage of an upcoming FDA public meeting to discuss its criteria for dietary supplements and whether they could be broadened to include substances that don’t come from food, vitamins, herbs or other traditional ingredients, National Today turned to Bob Durkin for commentary.

news March 12, 2026

Ivan Wasserman Quoted in “MAHA Finds it Footing — and Limits — in Year Two Under RFK, Jr.”

In a story for SupplySide Supplement Journal regarding the progress of the Make America Healthy Again movement, Ivan Wasserman commented, “While there plans are obviously and intentionally vague at this point, the hope is FDA will embark on a path to regulatory changes that will end in a smart, balanced approach to level the playing […]

news March 5, 2026

Ivan Wasserman Quoted in “Could 2026 be the Biggest Year for Dietary Supplements Since the Introduction of GMPs”

Ivan Wasserman spoke with NutraIngredients at Probiota in Dublin about a proposed rule that would require all ingredients claiming to be self-affirmed GRAS to submit to the FDA.

news March 4, 2026

Ivan Wasserman Quoted in “FDA Sets Meeting to Clarify DSHEA Definitions”

Following FDA’s announcement of a public meeting that will delve into definitional questions that figure into the filing of new dietary ingredient notifications, Ivan Wasserman spoke with SupplySide Supplement Journal. “I’m thrilled that the FDA has called this important meeting to continue the dialog that was started at a public meeting several years ago,” Ivan […]

news January 30, 2026

Ivan Wasserman Quoted in “FDA Releases HFP Priorities: All Eyes on Modernizing Dietary Supplement Oversight, GRAS, NDIs”

Ivan Wasserman spoke with NutraIngredients about the dietary supplement industry’s reaction to FDA’s Human Food Program 2026 priority deliverables.

What's Now

Ivan Wasserman Quoted in “Could 2026 be the Biggest Year for Dietary Supplements Since the Introduction of GMPs”

Ivan Wasserman spoke with NutraIngredients at Probiota in Dublin about a proposed rule that would require all ingredients claiming to be self-affirmed GRAS to submit to the FDA.

see all news >